<DOC>
	<DOCNO>NCT00184821</DOCNO>
	<brief_summary>In proof-of-concept study , forearm vulnerability ischemic exercise study patient type 1 diabetes mellitus without prior ischemic preconditioning ( short period ischemia protect subsequent ischemic exercise ) . Annexin A5 scintigraphy use quantify subtle sign mild reversible forearm injury result ischemic exercise . The following hypothesis test : 1 . Patients type 1 diabetes vulnerable ischemic injury compare previously study healthy volunteer . 2 . Ischemic preconidtioning still present patient type 1 diabetes . Depending validity hypothesis 2 , effect short pharmacological intervention study vulnerability forearm ischemia/reperfusion injury absence presence local forearm ischemic preconditioning .</brief_summary>
	<brief_title>Ischemic Injury Ischemic Preconditioning Diabetes</brief_title>
	<detailed_description>All patient study supine position overnight fast , plasma glucose level monitor . In first 8 patient intravenous insulin administer need , reach target glucose level 5-7 mmol/l . Patients subject 10 minute forearm ischemia ( non-dominant arm ) , combine handgripping 50 % maximal force exhaustion . Upon reperfusion , Tc-99m-HYNIC-Annexin A5 inject intravenously . Targeting annexin A5 thenar muscle forearm flexor muscle quantify percentage difference radioactivity experimental control side . This procedure perform twice ( randomized cross-over design ) , least 2 week interval , either without 10 minute ischemia follow 10 minute reperfusion prior ischemic exercise . Depending result study , substudies perform study effect diazoxide ( K-ATP channel opener , may mimic ischemic preconditioning ) , glibenclamide ( K-ATP channel blocker , may inhibit ischemic preconditioning ) adenosine ( infusion brachial artery non-dominant arm substitute ischemic preconditioning ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<mesh_term>Diazoxide</mesh_term>
	<mesh_term>Annexin A5</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>type 1 diabetes mellitus age 1850 year hypertension ( systolic blood pressure &gt; 140 mmHg and/or diastolic blood pressure &gt; 90 mmHg cardiovascular disease ( coronary artery insufficiency , CVA/TIA , peripheral artery disease HbA1c &gt; 9 % Body Mass Index &lt; 25 kg/m2 Unable stop comedication ( insulin ) 1 week Previous exposure radiation ( diagnostic therapeutic ) past year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Ischemia</keyword>
	<keyword>Annexin A5 scintigraphy</keyword>
</DOC>